The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancer
Background: This study aimed to construct a nomogram based on CAF features to predict the cancer-specific survival (CSS) rates of locally advanced rectal cancer (LARC) patients. Methods: The EPIC algorithm was employed to calculate the proportion of CAFs. based on the differentially expressed genes...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024047042 |
_version_ | 1797235540589805568 |
---|---|
author | Huajun Cai Yijuan Lin Yong Wu Ye Wang Shoufeng Li Yiyi Zhang Jinfu Zhuang Xing Liu Guoxian Guan |
author_facet | Huajun Cai Yijuan Lin Yong Wu Ye Wang Shoufeng Li Yiyi Zhang Jinfu Zhuang Xing Liu Guoxian Guan |
author_sort | Huajun Cai |
collection | DOAJ |
description | Background: This study aimed to construct a nomogram based on CAF features to predict the cancer-specific survival (CSS) rates of locally advanced rectal cancer (LARC) patients. Methods: The EPIC algorithm was employed to calculate the proportion of CAFs. based on the differentially expressed genes between the high and low CAF proportion subgroups, prognostic genes were identified via LASSO and Cox regression analyses. They were then used to construct a prognostic risk signature. Moreover, the GSE39582 and GGSE38832 datasets were used for external validation. Lastly, the level of immune infiltration was evaluated using ssGSEA, ESTIMATE, CIBERSORTx, and TIMER. Results: A higher level of CAF infiltration was associated with a worse prognosis. Additionally, the number of metastasized lymph nodes and distant metastases, as well as the level of immune infiltration were higher in the high CAF proportion subgroup. Five prognostic genes (SMOC2, TUBAL3, C2CD4A, MAP1B, BMP8A) were identified and subsequently incorporated into the prognostic risk signature to predict the 1-, 3-, and 5-year CSS rates in the training and validation sets. Differences in survival rates were also determined in the external validation cohort. Furthermore, independent prognostic factors, including TNM stage and risk score, were combined to established a nomogram. Notably, our results revealed that the proportions of macrophages and neutrophils and the levels of cytokines secreted by M2 macrophages were higher in the high-risk subgroup. Finally, the prognostic genes were significantly associated with the level of immune cell infiltration. Conclusion: Herein, a nomogram based on CAF features was developed to predict the CSS rate of LARC patients. The risk model was capable of reflecting differences in the level of immune cell infiltration. |
first_indexed | 2024-04-24T16:49:35Z |
format | Article |
id | doaj.art-6f3d98e4ef024469b1b0fbfff75cfef5 |
institution | Directory Open Access Journal |
issn | 2405-8440 |
language | English |
last_indexed | 2024-04-24T16:49:35Z |
publishDate | 2024-04-01 |
publisher | Elsevier |
record_format | Article |
series | Heliyon |
spelling | doaj.art-6f3d98e4ef024469b1b0fbfff75cfef52024-03-29T05:50:46ZengElsevierHeliyon2405-84402024-04-01107e28673The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancerHuajun Cai0Yijuan Lin1Yong Wu2Ye Wang3Shoufeng Li4Yiyi Zhang5Jinfu Zhuang6Xing Liu7Guoxian Guan8Department of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Department of Colorectal Surgery, National Regional Medical Center, Binhai Campus of The First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Corresponding author.Background: This study aimed to construct a nomogram based on CAF features to predict the cancer-specific survival (CSS) rates of locally advanced rectal cancer (LARC) patients. Methods: The EPIC algorithm was employed to calculate the proportion of CAFs. based on the differentially expressed genes between the high and low CAF proportion subgroups, prognostic genes were identified via LASSO and Cox regression analyses. They were then used to construct a prognostic risk signature. Moreover, the GSE39582 and GGSE38832 datasets were used for external validation. Lastly, the level of immune infiltration was evaluated using ssGSEA, ESTIMATE, CIBERSORTx, and TIMER. Results: A higher level of CAF infiltration was associated with a worse prognosis. Additionally, the number of metastasized lymph nodes and distant metastases, as well as the level of immune infiltration were higher in the high CAF proportion subgroup. Five prognostic genes (SMOC2, TUBAL3, C2CD4A, MAP1B, BMP8A) were identified and subsequently incorporated into the prognostic risk signature to predict the 1-, 3-, and 5-year CSS rates in the training and validation sets. Differences in survival rates were also determined in the external validation cohort. Furthermore, independent prognostic factors, including TNM stage and risk score, were combined to established a nomogram. Notably, our results revealed that the proportions of macrophages and neutrophils and the levels of cytokines secreted by M2 macrophages were higher in the high-risk subgroup. Finally, the prognostic genes were significantly associated with the level of immune cell infiltration. Conclusion: Herein, a nomogram based on CAF features was developed to predict the CSS rate of LARC patients. The risk model was capable of reflecting differences in the level of immune cell infiltration.http://www.sciencedirect.com/science/article/pii/S2405844024047042Cancer-associated fibroblastsLocally advanced rectal cancerPrognostic risk signatureNomogramImmune landscape |
spellingShingle | Huajun Cai Yijuan Lin Yong Wu Ye Wang Shoufeng Li Yiyi Zhang Jinfu Zhuang Xing Liu Guoxian Guan The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancer Heliyon Cancer-associated fibroblasts Locally advanced rectal cancer Prognostic risk signature Nomogram Immune landscape |
title | The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancer |
title_full | The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancer |
title_fullStr | The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancer |
title_full_unstemmed | The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancer |
title_short | The prognostic model and immune landscape based on cancer-associated fibroblast features for patients with locally advanced rectal cancer |
title_sort | prognostic model and immune landscape based on cancer associated fibroblast features for patients with locally advanced rectal cancer |
topic | Cancer-associated fibroblasts Locally advanced rectal cancer Prognostic risk signature Nomogram Immune landscape |
url | http://www.sciencedirect.com/science/article/pii/S2405844024047042 |
work_keys_str_mv | AT huajuncai theprognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT yijuanlin theprognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT yongwu theprognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT yewang theprognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT shoufengli theprognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT yiyizhang theprognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT jinfuzhuang theprognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT xingliu theprognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT guoxianguan theprognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT huajuncai prognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT yijuanlin prognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT yongwu prognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT yewang prognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT shoufengli prognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT yiyizhang prognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT jinfuzhuang prognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT xingliu prognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer AT guoxianguan prognosticmodelandimmunelandscapebasedoncancerassociatedfibroblastfeaturesforpatientswithlocallyadvancedrectalcancer |